Pharmlink Ltd

	Page
Balance Sheet	1
Notes to the Financial Statements	2—3

Registered number: 15536636

		31 March 2026		31 March 2025
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		1,925		1,414

			1,925		1,414
CURRENT ASSETS
Debtors	5	3,025		2,380
Cash at bank and in hand		15,364		8,617

		18,389		10,997
Creditors: Amounts Falling Due Within One Year	6	(17,472 )		(8,673 )

NET CURRENT ASSETS (LIABILITIES)			917		2,324

TOTAL ASSETS LESS CURRENT LIABILITIES			2,842		3,738

NET ASSETS			2,842		3,738

CAPITAL AND RESERVES
Called up share capital	7		100		100
Profit and Loss Account			2,742		3,638

SHAREHOLDERS' FUNDS			2,842		3,738

For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr H I Chowdhary

Director

05/08/2026

The notes on pages 2 to 3 form part of these financial statements.

1. General Information

Pharmlink Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15536636 . The registered office is Solent Pharmacy, 9 St James Road, Southampton, Hampshire, SO15 5FB.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Computer Equipment

33% on cost

2.4. Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 2 (2025: 2)

4. Tangible Assets

	Computer Equipment
	£
Cost
As at 1 April 2025	1,464
Additions	1,108

As at 31 March 2026	2,572

Depreciation
As at 1 April 2025	50
Provided during the period	597

As at 31 March 2026	647

Net Book Value
As at 31 March 2026	1,925

As at 1 April 2025	1,414

Page 2

Page 3

Pharmlink Ltd

Notes to the Financial Statements (continued)

For The Year Ended 31 March 2026

5. Debtors

	31 March 2026	31 March 2025
	£	£
Due within one year
Trade debtors	3,025	2,380

6. Creditors: Amounts Falling Due Within One Year

	31 March 2026	31 March 2025
	£	£
Amounts owed to group undertakings	1,297	1,297
Other creditors	19	29
Taxation and social security	16,156	7,347

	17,472	8,673

7. Share Capital

	31 March 2026	31 March 2025
	£	£
Allotted, Called up and fully paid	100	100

Page 3